Compare SUPN & XRAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | XRAY |
|---|---|---|
| Founded | 2005 | 1899 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2012 | 1987 |
| Metric | SUPN | XRAY |
|---|---|---|
| Price | $51.67 | $13.74 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 12 |
| Target Price | ★ $61.60 | $13.80 |
| AVG Volume (30 Days) | 754.8K | ★ 4.3M |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 4.65% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $681,539,000.00 | ★ $3,624,000,000.00 |
| Revenue This Year | $8.18 | N/A |
| Revenue Next Year | $22.15 | $0.67 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.54 | N/A |
| 52 Week Low | $29.16 | $9.85 |
| 52 Week High | $57.65 | $19.67 |
| Indicator | SUPN | XRAY |
|---|---|---|
| Relative Strength Index (RSI) | 61.38 | 64.99 |
| Support Level | $47.29 | $11.79 |
| Resistance Level | $49.71 | $12.67 |
| Average True Range (ATR) | 1.40 | 0.47 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 100.00 | 97.60 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).